Have you ever wondered how jet-setting across the globe might affect your gut health? A recent study has dug into this intriguing question, revealing that travel can have some unexpected impacts on t..
Genetic variant databases are vital for interpreting genetic variations in clinical settings and research. However, misclassified variants can create challenges. A recent study analyzed archives of C..
The ClinGen Sequence Variant Interpretation Working Group has published recommendations on how to evaluate splicing variant data, offering standardized guidance on evidence codes and functional data ..
Exciting news in genetic research! The Human Pangenome Reference Consortium has unveiled an improved version of the human pangenome reference. This comprehensive reference includes genetic informatio..
Depression is a serious mental health issue affecting over 280 million people worldwide. Recent research has revealed a potential link between gut health and the development of major depressive disor..
Researchers have developed a method called "Mendelian Phenotype Search Engine" (MPSE) to identify which sick infants in the neonatal intensive care unit (NICU) would benefit most from newborn whole-g..
What is the percentage of infant deaths caused by genetic diseases? According to a study published in JAMA Network: 41% of infant deaths were caused by single-gene diseases. For 30% of th..
A recent study in Nature found that people who live together tend to have similar microbes in their gut and mouth. The longer they live together, the more alike their microbiomes become. This suggest..
What makes melanoma (skin cancer) immortal? Scientists discover a combination of genetic alterations that enables cancer to live forever. A study published in Science describes how the combinati..
A recent paper published in Science reports that viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain modern viruses. The r..
Medicover Genetics’ technology transfer platform offers comprehensive testing in a single sequencing run, making it a unique and efficient solution for laboratories of any size. With our Technology Transfer platform, laboratories can perform multi-disciplinary genetic tests such as NIPT, cardiac, hereditary cancer, carrier screening, and metabolic testing all in a single sequencing run. This improves turnaround time and reduces operational costs while ensuring high-quality results with no compromise on accuracy. Our comprehensive testing approach is ideal for laboratories looking to provide a wide range of genetic tests to their healthcare associates and patients.
Our Technology Transfer platform workflow is designed to minimize the risk of errors, reduce hands-on processing and increase the accuracy of test results, providing confidence to patients and physicians in making informed decisions with our user-friendly protocols. The implementation of these protocols ensures that laboratory personnel are trained to follow standardized procedures, reducing the likelihood of human error, and increasing the quality of results.
Medicover Genetics’ versatile Technology Transfer platform can be integrated in a single workflow, offering a multidisciplinary portfolio of genetic tests. VERACITY, VERACITY High Content (HC) and TarCET IVD kits are CE-marked and include user friendly color identification formatting. VERACITY and VERACITY HC kits contain 96 reactions and TarCET IVD kits contain 16 reactions.
We work closely with laboratories to meet their unique needs and goals. We understand that every laboratory is different, and we tailor our approach to accommodate the specific requirements of each partner. In collaboration with our partners, we design a seamless integrated process, from initial setup to ongoing support and maintenance. Our experienced team provides technical, commercial, and marketing assistance to ensure a successful partnership and optimal performance. We aim to build long-lasting partnerships that are mutually beneficial.
